EUVIMEDObjevte EUVIMED
Crossref

Exploring the dynamics of T‐cell responses: a combined approach using EdU incorporation and proliferation dye dilution assay

Hilde Raaphorst, Sinéad Lougheed, Latifa Saou, Nadine D van Kleef, Irma Rensink, Anja Ten Brinke, Julian J Freen-van Heeren, Annelies W Turksma

Immunology & Cell Biology · 2025-02 · 103 (2) · 178-191

DOI: 10.1111/imcb.12845 ↗

At a glance

Journal article in Immunology & Cell Biology, published online on 2024-12-30. Written by Hilde Raaphorst and 7 co-authors. Institution: R&D, Sanquin Diagnostic Services, Amsterdam, The Netherlands. Major MEDLINE topics: T-Lymphocytes, Deoxyuridine. Cited 2 times so far (Crossref); 28 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Understanding antigen‐specific T‐cell responses is crucial for advancing immunotherapies and vaccine development. This study proposes a novel approach combining two complementary assays: the 5‐ethynyl‐2′‐deoxyuridine (EdU) incorporation assay (tracking proliferation over 0–48 h) and the VPD450 dye dilution assay (tracking proliferation over 4–6 days). Integrating these techniques provides additional insights into T‐cell proliferation kinetics. Both assays were independently optimized using anti‐CD3 and anti‐CD28 polyclonal T cell stimulation. 1 μM VPD450 is suitable for assessing T‐cell proliferation. The EdU concentration should match the stimulation strength, requiring higher concentrations to efficiently track DNA replication detection during increased cellular division. Day 5 was the optimal read‐out day for the EdU incorporation assay. We then combined the VPD450 dye dilution and EdU incorporation assays. As a proof of principle, we stimulated PBMCs from healthy donors with tetanus toxoid to assess antigen‐specific T‐cell responses. Additionally, we demonstrated the assay's application in drug research by evaluating proliferation in a mixed lymphocyte reaction with abatacept, an agonistic anti‐CTLA‐4 antibody. This combined approach offers qualitative insights into T‐cell proliferation kinetics, beneficial for assessing novel vaccine efficiency or for designing new treatments targeting T cell proliferation, such as in autoimmune settings.

Subjects

MeSH terms (MEDLINE)

T-LymphocytesDeoxyuridineCell ProliferationHumansLymphocyte ActivationTetanus ToxoidAbatacept

Author keywords

EdUT cellsVPD450proliferation assayvaccine

Substances

5-ethynyl-2'-deoxyuridineDeoxyuridineTetanus ToxoidAbatacept

Authors and institutions

  • R&D, Sanquin Diagnostic Services, Amsterdam, The Netherlands.
  • Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, The Netherlands.

Cite

APA

Raaphorst, H., Lougheed, S., Saou, L., van Kleef, N. D., Rensink, I., Ten Brinke, A., Freen-van Heeren, J. J., & Turksma, A. W. (2025). Exploring the dynamics of T‐cell responses: a combined approach using EdU incorporation and proliferation dye dilution assay. Immunology & Cell Biology, 103(2), 178-191. https://doi.org/10.1111/imcb.12845

Vancouver

Raaphorst H, Lougheed S, Saou L, van Kleef ND, Rensink I, Ten Brinke A, et al. Exploring the dynamics of T‐cell responses: a combined approach using EdU incorporation and proliferation dye dilution assay. Immunology & Cell Biology. 2025;103(2):178-191. doi:10.1111/imcb.12845

BibTeX
@article{Raaphorst2025,
  author = {Raaphorst, Hilde and Lougheed, Sinéad and Saou, Latifa and van Kleef, Nadine D and Rensink, Irma and Ten Brinke, Anja and Freen-van Heeren, Julian J and Turksma, Annelies W},
  title = {Exploring the dynamics of T‐cell responses: a combined approach using EdU incorporation and proliferation dye dilution assay},
  journal = {Immunology & Cell Biology},
  year = {2025},
  volume = {103},
  number = {2},
  pages = {178--191},
  doi = {10.1111/imcb.12845}
}
Start for free →